Clin2
NCT07250880Possibly a fitNot yet recruiting

Ceramide blood levels in people with acne

Acne Vulgaris

Part of Skin clinical trials.

This study is comparing levels of certain fats (ceramides) in the blood of people with acne versus healthy volunteers. Researchers want to see if these fats are linked to acne severity, which could lead to better treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
15 years to 40 years
Study type
Observational

Who can take part

  • You are between 15 and 40 years old.
  • You have acne vulgaris (the common kind of acne).
  • You have not used strong acne treatments (like isotretinoin or antibiotics) in the last 3 months.
  • You are not pregnant or breastfeeding.
  • You are not taking medications or supplements that affect your body's cholesterol or fat levels.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06869109Not yet recruiting
Blood markers in acne severity

This study measures two substances in the blood (CXCL10 and CRP) to see if they relate to acne severity. It may help understand inflammation in acne and guide future treatments.

Asyut, Asyut Governorate
NCT07062081Not yet recruiting
Acne and cholesterol study in young adults

This study looks at the link between acne and cholesterol levels in young adults. It enrolls healthy volunteers who have never had acne and aren't taking any medications to see if there is a connection.

Sohag
NCT06925386Not yet recruiting· Phase 2
Studying skin bacteria balance as a new acne treatment

This study tests whether balancing the bacteria on your skin can help treat mild to moderate acne. Researchers will take facial photos and follow your progress to see if this new approach works.

Denpasar, Bali
NCT07054398Recruiting
Catestatin levels in acne patients

This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.

Aswān
NCT07449156Not yet recruiting· Phase 1/Phase 2
Testing HB0043 for moderate to severe acne

This trial tests a new medicine, HB0043, to see if it helps adults with moderate to severe facial acne. You cannot use other acne treatments during the study.

Jinan, Shandong
NCT07411638Not yet recruiting
Acne study: looking at how skin changes in mild to severe acne

This study is for people aged 18 to 25 with mild, moderate, or severe facial acne, and also for healthy volunteers without acne. Researchers want to learn more about acne by taking skin samples and blood samples, and no experimental treatments are given.

Hear when a new Acne Vulgaris trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.